Literature DB >> 12851537

Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer.

Shrimati Shetty1, Kanjaksha Ghosh, Dipika Mohanty.   

Abstract

Large numbers of activated partial thromboplastin time (aPTT) reagents are sold in the market. The phospholipid content and its source, nature and the amount of activators are highly varied in different aPTT reagents. The present study was undertaken to evaluate which of the four aPTT reagents commonly used is suitable as an all-purpose reagent for a modest haemostasis laboratory. Four aPTT reagents (reagent A, Platelin LS; reagent B, Silimat; reagent C, Actin FSL; reagent D, CK Prest) were tested against 75 different plasmas obtained from normal patients as well as from patients with different haemostatic problems. All the tests were conducted by one of us (S.S.) in duplicates. Different aPTT reagents missed different proportions of mild factor VIII and factor IX deficiency (36.4, 18.2, 4.6 and 13.6% for reagents A, B, C and D, respectively) and showed abnormal results with normal plasmas (i.e. more than 5 s prolongation) (29.2, 25, 8.3 and 12.5% for reagents A, B, C and D, respectively). All the reagents faithfully picked up moderate and severe factor VIII and factor IX deficiency. There was no difference among the four aPTT reagents regarding their ability to prolong aPTT to therapeutic dosage of heparin or in their ability to give comparable factor VIII or factor IX levels in one-stage aPTT-based assays. There were differences in aPTT reagents in their ability to pick up mild deficiency of coagulation factor VIII and factor IX. Some reagents showed abnormal aPTT results in mild cases of factor VIII and factor IX deficiency without producing a large number of falsely prolonged aPTT with normal plasma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851537     DOI: 10.1097/00001721-200307000-00011

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

1.  The Prevalence of Coagulopathy and Associated Factors Among Adult Type II Diabetes Mellitus Patients Attending the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.

Authors:  Fasil Getu; Melak Aynalem; Segenet Bizuneh; Bamlaku Enawgaw
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-24       Impact factor: 3.168

2.  Recombinant FIX Fc fusion protein activity assessment with the one-stage clotting assay: A multicenter, assessor-blinded, prospective study in Japan (J-Field Study).

Authors:  Katsuyuki Fukutake; Tomomi Kobayashi; Jurg M Sommer; Toshiyuki Hirakata
Journal:  Int J Lab Hematol       Date:  2019-12-10       Impact factor: 2.877

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.